Update on advances in molecular PET in urological oncology
about
Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation.11C-Choline positive but 18F-FDG negative pancreatic metastasis from renal cell carcinoma on PET.Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD11C-Choline-Avid but 18F-FDG-Nonavid Prostate Cancer with Lymph Node Metastases on Positron Emission Tomography.Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer.
P2860
Update on advances in molecular PET in urological oncology
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Update on advances in molecular PET in urological oncology
@ast
Update on advances in molecular PET in urological oncology
@en
type
label
Update on advances in molecular PET in urological oncology
@ast
Update on advances in molecular PET in urological oncology
@en
prefLabel
Update on advances in molecular PET in urological oncology
@ast
Update on advances in molecular PET in urological oncology
@en
P2093
P2860
P1476
Update on advances in molecular PET in urological oncology
@en
P2093
Hossein Jadvar
Kazuhiro Kitajima
Kazuhito Fukushima
Ryogo Minamimoto
Shingo Yamamoto
Takao Kamai
P2860
P2888
P304
P356
10.1007/S11604-016-0553-3
P577
2016-05-24T00:00:00Z
P6179
1006750364